Global Market Study on Neurosurgical Products: Asia Pacific to Witness Highest Growth by 2022


  • Published On : Jul-2015 |
  • Pages : 86 Pages |
  • Format :

Neurosurgery is a branch of medicine that deals with prevention, diagnosis, and treatment of nervous system disorders and rehabilitation of patients suffering from the disorder post-surgery. Neurosurgery is mainly performed for treating neuro-trauma and intracranial hemorrhage. Brain stroke is one of the major causes of hemorrhage.The major reason for stroke is ischemia, wherein supply of blood to the brain is suddenly interrupted. Due to lack of proper blood supply, the brain starves of oxygen and glucose, which initiates various molecular reactions in the brain leading to brain damage. The extent of brain damage depends upon the duration of interruption of blood supply. Another cause of brain hemorrhage is a neural aneurysm. According to the American Heart Association, approximately 1.5%–5% people across the globe develop a cerebral aneurysm in their lifetime. Elderly people are more susceptible to neurological disorders as compared to other adults. With surging aging population, the incidence of neurodegenerative diseases is increasing, in turn, driving demand for effective neurosurgical products for their treatment.

Among regions, North America dominates the global market for neurosurgical products due to a rapid rise in aging population, increasing healthcare expenditure, and developed healthcare infrastructure in the region. The neurosurgical products market in Asia-Pacific is expected to show high growth rates over the next five years, with China and India being the fastest-growing markets in the region. Key driving forces of the neurosurgical products market in developing countries are: large pool of patients, increasing disposable income, growing geriatric population, increasing incidence of brain tumor, rising healthcare awareness, growing healthcare expenditure, and improving healthcare infrastructure in these regions.

In addition, various government bodies are providing funds and grants for development of neurosurgical products, which is further fueling the growth of the global neurosurgical products market. On the other hand, availability of alternative treatment for neurological diseases, stringent regulatory requirements, and long approval time for new neurosurgical products are some of the factors inhibiting the growth of the global neurosurgical products market. However, growing demand for minimally invasive surgeries is projected to create significant growth opportunities for the global neurosurgical products market.

This report provides in-depth analysis and estimation of the neurosurgical products market for the period 2015–2022, considering 2014 as the base year for calculation. Moreover, data pertaining to current market dynamics, including market drivers, restraints, trends, and recent developments, has been provided in the report.

The market has been segmented on the basis of the following:

  • By product type
    • Shunts
    • Neurosurgical endoscope
    • Stereotactic radio-surgery systems
    • Embolization products
    • Aneurysm and AVM clips
    • Others
  • By condition
    • Hydrocephalus
    • Aneurysms
    • Arteriovenous Malformations
    • Pituitary and intracranial tumor
    • Others
  • By procedure
    • Open surgery
    • Neurovascular and minimally invasive surgery

Key geographies evaluated in this report are:

  • North America
    • U.S.
    • Rest of North America
  • Europe
    • France
    • Germany
    • U.K.
    • Rest of Europe
  • APAC
    • China
    • India
    • Japan
    • Rest of Asia Pacific

Key features of this report

  • Drivers, restraints, and challenges shaping the neurosurgical products market dynamics
  • Latest innovations and key events in the market
  • Analysis of business strategies of the top players in the market
  • Neurosurgical products market estimates and forecasts

The global neurosurgical products market is witnessing significant growth due to growing geriatric population. Moreover, increasing the incidence of brain tumors, growing government funding, and raising awareness about neurosurgical disorders are also driving the growth of the market. Furthermore, growing demand for minimally invasive surgeries is expected to create growth opportunities for the neurosurgical products market. However, stringent regulatory requirements, long approval times for new neurosurgical products, and availability of alternative treatment for neurosurgical diseases inhibit the growth of the market. 

The neurosurgical products market is anticipated to grow from an estimated US$3,685.8 Mn by the end of 2015 to US$7,756.2 Mn by 2022at a CAGR of 11.2% during the forecast period. North America is projected to be the largest market for neurosurgical products, with an aneurysm being the most prevalent neurosurgical condition, and embolization products being the most preferred neurosurgical product by the end of 2015. Asia Pacific is expected to be the fastest-growing region in terms of revenue while stereotactic radiosurgery is projected to be the fastest-growing neurosurgical product type segment over the forecast period.

Aneurysms are abnormal widening or bulging of parts of blood vessels due to weakening of the wall of the blood vessel.The global aneurysms segment is expected to grow from an estimated US$1,328.8 Mn by the end of2015 to US$2,866.1 Mn by 2022 at a CAGR of 11.6% during the forecast period.

neurosurgical-product-market

Top companies profiled in this report are:

  • Integra LifeSciences Holdings Corporation
  • KARL STORZ GmbH & Co. KG
  • Medtronic plc
  • Johnson & Johnson Services, Inc.
  • Stryker Corporation
  • Elekta AB
  • Terumo Corporation
  • Penumbra, Inc.
  • B. Braun Melsungen AG
  • Varian Medical Systems, Inc.
  • Other

Chapter 1 Preface 9

1.1 Report Description 9

1.2 Research Methodology 10

1.3 Assumptions 10

Chapter 2 Market Synopsis 11

Chapter 3 Porter’s Five Forces Analysis 12

3.1 Bargaining Power of Suppliers 12

3.2 Bargaining Power of Buyers 13

3.3 Threat of New Entrants 13

3.4 Threat of Substitutes 13

3.5 Intensity of Rivalry 14

Chapter 4 Industry Overview 15

4.1 Market Definition 15

4.2 Market Drivers 16

      4.2.1 Growing geriatric population 16

      4.2.2 Growing government funding 17

      4.2.3 Increasing incidence of brain tumor 18

      4.2.4 Rising awareness about neurological disorders 18

4.3 Impact Analysis of Market Drivers 18

4.4 Market Restraints 19

      4.4.1 Availability of alternative treatment for neurological diseases 19

      4.4.2 Stringent regulatory requirements and long approval times for new neurosurgical products 19

4.5 Impact Analysis of Market Restraints 20

4.6 Opportunities 20

      4.6.1 Growing demand for minimally invasive surgeries 20

Chapter 5 Global Market Size and Forecast 22

Chapter 6 Market Size and Forecast by Condition 30

6.1 Hydrocephalus 30

6.2 Aneurysms 32

6.3 Arteriovenous malformations 34

6.4 Pituitary and intracranial tumors 35

Chapter 7 Market Size and Forecast by Procedure 38

7.1 Open Neurosurgery 38

7.2 Neurovascular and Minimally Invasive Surgery 39

Chapter 8 Market Size and Forecast by Product Type 42

8.1 Shunts 42

8.2 Neurosurgical Endoscope 44

8.3 Stereotactic Radio-surgery System 46

8.4 Embolization Products 48

8.5 Aneurysm and AVM Clips 50

Chapter 9 Market Size and Forecast by Geography 52

9.1 North America 52

9.2 Europe 54

9.3 Asia-Pacific 56

Chapter 10 Competitive Scenario 60

10.1 Competitive Analysis 60

Chapter 11 Company Profiles 62

11.1 Integra LifeSciences Holdings Corporation 62

      11.1.1 Company overview 62

      11.1.2 Products and services 62

      11.1.3 Financial performance 63

      11.1.4 Key developments 64

11.2 KARL STORZ GmbH & Co. KG. 65

      11.2.1 Company overview 65

      11.2.2 Products and services 65

      11.2.3 Financial performance 66

      11.2.4 Key developments 66

11.3 Medtronic plc 67

      11.3.1 Company overview 67

      11.3.2 Products and services 68

      11.3.3 Financial performance 69

      11.3.4 Key developments 69

11.4 Johnson & Johnson Services, Inc. 70

      11.4.1 Company overview 70

      11.4.2 Products and services 71

      11.4.3 Financial performance 72

      11.4.4 Key developments 72

11.5 Stryker Corporation 73

      11.5.1 Company overview 73

      11.5.2 Products and services 73

      11.5.3 Financial performance 74

      11.5.4 Key developments 74

11.6 Elekta AB 75

      11.6.1 Company overview 75

      11.6.2 Products and services 75

      11.6.3 Financial performance 76

      11.6.4 Key developments 76

11.7 Terumo Corporation 77

      11.7.1 Company overview 77

      11.7.2 Products and services 77

      11.7.3 Financial performance 78

      11.7.4 Key developments 78

11.8 Penumbra, Inc. 79

      11.8.1 Company overview 79

      11.8.2 Products and services 79

      11.8.3 Financial performance 80

      11.8.4 Strategic development 80

11.9 B. Braun Melsungen AG 81

      11.9.1 Company overview 81

      11.9.2 Products and services 81

      11.9.3 Financial performance 83

      11.9.4 Key developments 83

11.10 Varian Medical Systems, Inc. 84

      11.10.1 Company overview 84

      11.10.2 Products and services 84

      11.10.3 Financial performance 85

      11.10.4 Key developments 85


List of Tables

TABLE 1 Market snapshot: Neurosurgical products market, 2015 and 2022 11

TABLE 2 Drivers for neurological products market: Impact analysis 18

TABLE 3 Restraints for neurological products market: Impact analysis 20

TABLE 4 Global neurosurgical products market size, by region, 2012 – 2014 (US$ Mn) 23

TABLE 5 Global neurosurgical products market size, by region, 2015 – 2022 (US$ Mn) 23

TABLE 6 Global neurosurgical products market size, by condition, 2012 – 2014 (US$ Mn)  24

TABLE 7 Global neurosurgical products market size, by condition, 2015 – 2022 (US$ Mn)  25

TABLE 8 Global neurosurgical products market size, by product type, 2012 – 2014 (US$ Mn)  26

TABLE 9 Global neurosurgical products market size, by product type, 2015 – 2022 (US$ Mn)  27

TABLE 10 Global neurosurgical products market size, by procedure, 2012 – 2014 (US$ Mn)  28

TABLE 11 Global neurosurgical products market size, by procedure, 2015 – 2022 (US$ Mn)  29

TABLE 12 Global hydrocephalus market size, by region, 2012 – 2014 (US$ Mn) 31

TABLE 13 Global hydrocephalus market size, by region, 2015 – 2022 (US$ Mn) 31

TABLE 14 Global aneurysms market size, by region, 2012 – 2014 (US$ Mn) 33

TABLE 15 Global aneurysms market size, by region, 2015 – 2022 (US$ Mn) 33

TABLE 16 Global arteriovenous malformations market size, by region, 2012 – 2014 (US$ Mn)  34

TABLE 17 Global neurosurgical products market size, by region, 2015 – 2022 (US$ Mn) 35

TABLE 18 Global pituitary and intracranial tumors market size, by region, 2012 – 2014 (US$ Mn) 36

TABLE 19 Global pituitary and intracranial tumors market size, by region, 2015 – 2022 (US$ Mn) 37

TABLE 20 Global open neurosurgery market size, by region, 2012 – 2014 (US$ Mn) 38

TABLE 21 Global open neurosurgery market size, by region, 2015 – 2022 (US$ Mn) 39

TABLE 22 Global neurovascular and minimally invasive surgery market size, by region, 2012 – 2014 (US$ Mn) 40

TABLE 23 Global neurovascular and minimally invasive surgery market size, by region, 2015 – 2022 (US$ Mn) 41

TABLE 24 Global shunts market size, by region, 2012 – 2014 (US$ Mn) 43

TABLE 25 Global shunts market size, by region, 2015 – 2022 (US$ Mn) 43

TABLE 26 Global neurosurgical endoscopes market size, by region, 2012 – 2014 (US$ Mn)  44

TABLE 27 Global neurosurgical endoscopes market size, by region, 2015 – 2022 (US$ Mn)  45

TABLE 28 Global stereotactic radio-surgery system market size, by region, 2012 – 2014 (US$ Mn) 47

TABLE 29 Global stereotactic radio-surgery system market size, by region, 2015 – 2022 (US$ Mn) 47

TABLE 30 Global embolization products market size, by region, 2012 – 2014 (US$ Mn) 49

TABLE 31 Global embolization products market size, by region, 2015 – 2022 (US$ Mn) 49

TABLE 32 Global aneurysm and AVM clips market size, by region, 2012 – 2014 (US$ Mn) 50

TABLE 33 Global aneurysm and AVM clips market size, by region, 2015 – 2022 (US$ Mn) 51

TABLE 34 North America neurosurgical products market size, by country, 2012 – 2014 (US$ Mn) 53

TABLE 35 North America neurosurgical products market size, by country, 2015 – 2022 (US$ Mn) 54

TABLE 36 Europe neurosurgical products market size, by country, 2012 – 2014 (US$ Mn) 55

TABLE 37 Europe neurosurgical products market size, by country, 2015 – 2022 (US$ Mn) 56

TABLE 38 Asia Pacific neurosurgical products market size, by country, 2012 – 2014 (US$ Mn)  58

TABLE 39 Asia Pacific neurosurgical products market size, by country, 2015 – 2022 (US$ Mn)  58

TABLE 40 Major product categories of Integra LifeSciences 62

TABLE 41 Product divisions of KARL STORZ 65

TABLE 42 Major product segments of Medtronic plc 68

TABLE 43 Product segments of Johnson & Johnson 71

TABLE 44 Major product segments of Stryker 73

TABLE 45 Major product categories of Elekta AB 75

TABLE 46 Major product segments of Terumo Corporation 77

TABLE 47 Product categories of Penumbra, Inc. 79

TABLE 48 Major product categories of B. Braun 81

TABLE 49 Product segments of Varian Medical Systems, Inc. 84


List of Figures

FIG. 1 Neurosurgical products market: Porter’s five forces analysis 12

FIG. 2 Major neurosurgical devices 15

FIG. 3 Aging population in major regions, 2000 – 2050 (% share in total population) 17

FIG. 4 Global neurosurgical products market value share, by region, 2014 22

FIG. 5 Global neurosurgical products market value share, by condition, 2014 24

FIG. 6 Global neurosurgical products market value share, by product type, 2014 25

FIG. 7 Global neurosurgical products market value share, by procedure, 2014 28

FIG. 8 Global hydrocephalus market value share, by region, 2014 30

FIG. 9 Global aneurysms market value share, by region, 2014 32

FIG. 10 Global arteriovenous malformations market value share, by region, 2014 34

FIG. 11 Global pituitary and intracranial tumors market value share, by region, 2014 36

FIG. 12 Global open neurosurgery market value share, by region, 2014 38

FIG. 13 Global neurovascular and minimally invasive surgery market value share, by region, 2014 40

FIG. 14 Global shunts market value share, by region, 2014 42

FIG. 15 Global neurosurgical endoscopes market value share, by region, 2014 44

FIG. 16 Global stereotactic radio-surgery system market value share, by region, 2014 46

FIG. 17 Global embolization products market value share, by region, 2014 48

FIG. 18 A global aneurysm and AVM clips market value share, by region, 2014 50

FIG. 19 North America neurosurgical products market value share, by country, 2014 53

FIG. 20 Europe neurosurgical products market value share, by country, 2014 55

FIG. 21 Asia Pacific neurosurgical products market value share, by country, 2014 57

FIG. 22 Market analysis of major players by product type 60

FIG. 23 Net revenue and net income of Integra LifeSciences Holdings Corporation, 2012 – 2014 (US$ Mn) 63

FIG. 24 Net sales and net earnings of Medtronic, 2012 – 2014 (US$ Mn) 69

FIG. 25 Total sales and net earnings of Johnson & Johnson, 2012 – 2014 (US$ Mn) 72

FIG. 26 Net sales and net earnings of Stryker, 2012 – 2014 (US$ Mn) 74

FIG. 27 Net sales and profit of Elekta AB, 2011 – 2013 (US$ Mn) 76

FIG. 28 Net sales and net income of Terum Corporation, 2012 – 2014 (US$ Mn) 78

FIG. 29 Sales and net income of B. Braun Melsungen, 2012 – 2014 (US$ Mn) 83

FIG. 30 Varian Medical Systems, Inc.’s revenue and net earnings, 2012 – 2014 (US$ Mn)  85

Back To Top